Calls
6
#603
Alpha Score 36.2
Lee Jeok-gyu
Strategist, SK Securities
Win Rate
16.7%
return
-3.5%
Loading charts...
Ticker
Side
Mentions
Opened
Entry
P&L
Thesis
Theme
Source
Long
Jul 06
$2381000.00
-8.4%
Samsung Electronics and SK hynix remain core long-term holdings. Even if Q2 earnings miss, any dip would be a buying opportunity because the global semiconductor uptrend is intact. Portfolio discipline favours building positions on weakness.
AI Memory
Long
Jul 06
$451000.00
-3.8%
KOSDAQ has fallen 33% from its peak due to severe liquidity distortions from leveraged ETFs, creating an extreme oversold condition. An eventual normalization will trigger strong rebounds in oversold large-cap KOSDAQ names across biotech, cosmetics, entertainment, and batteries. Specific names with tight stop-loss levels offer attractive risk/reward.
Batteries & Storage
Long
Jul 06
$216000.00
-6.2%
KOSDAQ has fallen 33% from its peak due to severe liquidity distortions from leveraged ETFs, creating an extreme oversold condition. An eventual normalization will trigger strong rebounds in oversold large-cap KOSDAQ names across biotech, cosmetics, entertainment, and batteries. Specific names with tight stop-loss levels offer attractive risk/reward.
Grid Equipment
Long
Jul 06
$77400.00
+0.1%
KOSDAQ has fallen 33% from its peak due to severe liquidity distortions from leveraged ETFs, creating an extreme oversold condition. An eventual normalization will trigger strong rebounds in oversold large-cap KOSDAQ names across biotech, cosmetics, entertainment, and batteries. Specific names with tight stop-loss levels offer attractive risk/reward.
Gaming & Entertainment
Long
Jul 06
$175800.00
-0.3%
KOSDAQ has fallen 33% from its peak due to severe liquidity distortions from leveraged ETFs, creating an extreme oversold condition. An eventual normalization will trigger strong rebounds in oversold large-cap KOSDAQ names across biotech, cosmetics, entertainment, and batteries. Specific names with tight stop-loss levels offer attractive risk/reward.
Pharma & Biotech
Long
Jul 06
$331000.00
-2.1%
KOSDAQ has fallen 33% from its peak due to severe liquidity distortions from leveraged ETFs, creating an extreme oversold condition. An eventual normalization will trigger strong rebounds in oversold large-cap KOSDAQ names across biotech, cosmetics, entertainment, and batteries. Specific names with tight stop-loss levels offer attractive risk/reward.
Pharma & Biotech
Showing 6 of 6 picks · sorted by mentions
Choose a mentions count to open ticker posts.
Lee Jeok-gyu has 6 trade ideas tracked on Buzzberg across 6 tickers since July 2026. Ranked #603 on the Buzzberg Alpha leaderboard. Most covered: 000660.KS, 041510.KQ, 010120.KS.
